Induction therapy in chronic hepatitis C: Déjà-vu with pegylated interferons?

Journal of Hepatology

Volumn 41, Issue 3, 2004, Pages 488-490

  Zeuzem, Stefan ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; INTERFERON; PEGINTERFERON; RIBAVIRIN; VIRUS RNA;

ANTIVIRAL ACTIVITY; CELL DEATH; CLINICAL TRIAL; COMPARATIVE STUDY; DEJA VU; DOSE RESPONSE; DRUG TOLERABILITY; EDITORIAL; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL; PRIORITY JOURNAL; VIROLOGY; VIRUS LOAD;

ANTIVIRAL AGENTS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; INTERFERON TYPE I, RECOMBINANT; POLYETHYLENE GLYCOLS; RNA, VIRAL;

EID: 4344581288     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.07.019     Document Type: Editorial

References (24)

1. S. Zeuzem, J.M. Schmidt, J.-H. Lee, B. Rüster, and W.K. Roth Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo Hepatology 23 1996 366 371
2. A.U. Neumann, N.P. Lam, H. Dahari, D.R. Gretch, T.E. Wiley, T.J. Layden, and A.S. Perelson Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy Science 282 1998 103 107
3. N.P. Lam, A.U. Neumann, D.R. Gretch, T.E. Wiley, A.S. Perelson, and A.J. Layden Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa Hepatology 26 1997 226 231
4. S. Zeuzem, J.M. Schmidt, J.H. Lee, M. von Wagner, G. Teuber, and W.K. Roth Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover Hepatology 28 1998 245 252
5. S. Zeuzem, E. Herrmann, J.-H. Lee, J. Fricke, A.U. Neumann, and M. Modi Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2a Gastroenterology 120 2001 1438 1447
6. A.U. Neumann, S. Zeuzem, M.J. Brunda, and J.H. Hoffman Rapid viral response to treatment with pegylated (40 kDa) interferon alfa-2A (Pegasys) is strongly predictive of a sustained virologic response in patients with chronic hepatitis C (CHC) Hepatology 32 2000 318A
7. M.L. Shiffman Use of high-dose interferon in the treatment of chronic hepatitis C Sem Liver Dis 19 1999 25 33
8. F.C. Bekkering, C. Stalgis, J.G. McHutchison, J.T. Brouwer, and A.S. Perelson Estimation of early hepatitis C viral clearance in patients receiving daily interferon and ribavirin therapy using a mathematical model Hepatology 33 2001 419 423
9. R.L. Carithers Jr, S. Zeuzem, M.P. Manns, J.G. Mc Hutchison, R.P. Perrillo, and R. Bailey Multicenter, randomized, controlled trial comparing high dose daily induction interferon plus ribavirin versus standard interferon alfa-2B plus ribavirin Hepatology 32 2000 317A
10. H. Van Vlierberghe, G. Leroux-Roels, M. Adler, N. Bourgeois, F. Nevens, Y. Horsmans, and A multicentre randomized controlled trial Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients J Viral Hepat 10 2003 460 466
11. K. Bjoro, H. Bell, K.B. Hellum, K. Skaug, N. Raknerud, and P. Sandvei Effect of combined interferon-alpha induction therapy and ribavirin on chronic hepatitis C infection: a randomized multicentre study Scand J Gastroenterol 37 2002 226 232
12. T.J. Layden, J.E. Layden, K.R. Reddy, R.S. Levy-Drummer, J. Poulakos, and A.U. Neumann Induction therapy with consensus interferon (CIFN) does not improve sustained virologic response in chronic hepatitis C J Viral Hepat 9 2002 334 339
13. P. Ferenci, H. Brunner, K. Nachbaur, C. Datz, M. Gschwantler, H. Hofer, and Australian Hepatitis Study Group Combination of interferon induction therapy and ribavirin in chronic hepatitis C Hepatology 34 2001 1006 1011
14. S. Zeuzem, C. Welsch, and E. Herrmann Pharmacokinetics of peginterferons Semin Liver Dis 23 2003 23 28
15. S. Zeuzem, S.V. Feinman, J. Rasenack, E.J. Heathcote, M.Y. Lai, and E. Gane Peginterferon alfa-2a in patients with chronic hepatitis N Engl J Med 343 2000 1666 1672
16. K.L. Lindsay, C. Trepo, T. Heintges, M.L. Shiffman, S.C. Gordon, J.C. Hoefs, and Hepatitis Interventional Therapy Group A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C Hepatology 34 2001 395 403
17. M.P. Manns, J.G. McHutchison, S.C. Gordon, V.K. Rustgi, M. Shiffman, and R. Reindollar Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 358 2001 958 965
18. M.W. Fried, M.L. Shiffman, K.R. Reddy, C. Smith, G. Marinos, and F.L. Goncales Jr Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 2002 975 982
19. S.J. Hadziyannis, H. Sette Jr, T.R. Morgan, V. Balan, M. Diago, P. Marcellin, and PEGASYS International Study Group Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 140 2004 346 355
20. M. Buti, F. Sanchez-Avila, Y. Lurie, C. Stalgis, A. Valdes, M. Martell, and R. Esteban Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin Hepatology 35 2002 930 936
21. S. Bruno, C. Camm, V. Di Marco, M. Rumi, M. Vinci, and M. Camozzi Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial J Hepatol 41 2004 474 481
22. J.M. Vrolijk, F.C. Bekkering, J.T. Brouwer, B.E. Hansen, and S.W. Schalm High sustained virological response in chronic hepatitis C by combining induction and prolonged maintenance therapy J Viral Hepat 10 2003 205 209
23. T. Berg, M. von Wagner, H. Hinrichsen, P. Buggisch, T. Goeser, and J. Rasenack Comparison of 48 or 72 weeks of treatment with peginterferon alfa-2a (40 KD), (Pegasys) plus ribavirin (Copegus) in treatment-naive patients with chronic hepatitis C infected with HCV genotype 1 Hepatology 38 2003 317A
24. J.M. Sanchez-Tapias, M. Diago, P. Escartin, J. Enriquez, R. Moreno, and M. Romero-Gomez Sustained virological response after prolonged treatment with peginterferon alfa-2a (40 KD) (Pegasys) and ribavirin (Copegus) in treatment-naive patients with chronic hepatitis C and detectbale HCV RNA after week 4 of therapy: teravic-4 study J Hepatol 40 2004 150